Stephan Rogalla, M.D. Ph.D.

Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology Affiliate, Medicine - Med/Gastroenterology and Hepatology

Academic Appointments

Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Affiliate, Medicine - Med/Gastroenterology and Hepatology
Member, Maternal & Child Health Research Institute (MCHRI)

Honors & Awards

High-dimensional Atlas of Tissue Architecture & Microbiome in Pediatric Crohn’s Disease, Maternal and Child Health Research Institute (07/2022 - 06/2024)
Ultrabright Theranostic SERRS Nanoparticles for Early Cancer Detection in Gastrointestinal Endoscopy, National Institute of Health, National Cancer Institute (06/2021 - 05/2025)
Multiplexed Imaging to Improve Diagnosis and Treatment for Patient Suffering from Gulf War Illness, Department of Defense (07/2021 - 07/2023)
Synergy Award, Kenneth Rainin Foundation (02/2018-02/2020)
Seed Grant Esophagus Disease, Division of Gastroenterology and Hepatology, Stanford Medicine (04/2018-03/2019)
Seed Grant, Canary Foundation (2016-2017)
Postdoctoral Fellowship, Will Foundation (10/2012 - 09/2013)
Scholarship for extraordinary Attainment, Konrad-Adenauer Foundation (06/2002 - 11/2006)

Boards, Advisory Committees, Professional Organizations

Member, American Gastroenterological Association (AGA) (2017 - Present)
Chair, Intra-operative Imaging Study Group ESMI (2016 - Present)
Member, AACR (2014 - Present)
Member, European Society of Molecular Imaging (2014 - Present)
Member, ASCO (2014 - Present)
Member, World Molecular Imaging Society (2013 - Present)

Projects

Development of new Imaging Tools in Neoplasia of the GI-Tract, Stanford University (October 1, 2012 - Present)

Modern anti-cancer therapies have extended the survival times for many cancer patients but there is still improvements to be made as cancer mortality rates have, except for a few types of cancer, remained consistently high over the last five decades. By identifying highly sensitive imaging probes for the detection of cancer and its pre-steps we will improve outcomes for patients with the cancer through early detection, guided resection and thereby contribute to the reduction of the morbidity and mortality due to this malignant disease. In future those tools could work as well a therapeutics, which would open a new field - THERANOSTIC.

Location

350 Campus Drive, Stanford, USA
Guided resection of medulloblastoma using integrated optical tools for multimodality imaging, Stanford University
Location

318 Campus Drive, Stanford, Ca 94305

Collaborators
- Gerald Grant, Professor, Stanford University
Precision Medicine in Inflammatory Bowel Disease, Stanford University
Development of new predictive biomarkers for IBD using multiparametric studies.

Location

Stanford

Collaborators
- Garry Nolan, Stanford University

Professional Education

Postdoctoral Fellowship, Stanford Medical School, Department of Pediatrics Molecular Imaging Program at Stanford (MIPS), Molecular Imaging: Early Detection and Guided Resection of Malignancies (2015)
Residency and Fellowship, Charité University Medicine Berlin, Germany, Gastroenterology, Oncology (2010)
Residency, Charité University Medicine Berlin, Germany, Gerneral, Visceral, Vascular and Thoracic Surgery (2007)

Community and International Work

Chair Intra-operative Imaging Interest Group

Topic

Partnering Organization(s)

European Society for Molecular Imaging (ESMI)

Populations Served

Scientists in the Field of Imaging

Location

International

Ongoing Project

true

Opportunities for Student Involvement

true

Patents

Stefan Harmasen, Stephan Rogalla, Sanjiv Gambhir. "United States Patent 62/639,795 Functional Dyes for Early Lesion Detection", Leland Stanford Junior University, Mar 7, 2018

Current Research and Scholarly Interests

The research interest of myself and my lab are in the field of early cancer detection using targeted molecular spies to highlight (pre)cancerous lesions. We as well aim to improve precision medicine in autoimmune disorders like inflammatory bowel disease and oncology.

Clinical Trials

FluorescentProbeVGT-309 to ID CancerousColorectalLesions During WhiteLight&NIR Augmented Colonoscopy Not Recruiting
More
The purpose of this study is to determine the safety and feasibility of VGT-309 for the visualization of colorectal tumors in real-time using near-infrared (NIR) fluorescence endoscopy. In addition, signatures of 50+ biomarkers will be evaluated in biopsies using CODEX multi-plexing.

Stanford is currently not accepting patients for this trial. For more information, please contact Tabera, Joaquin, .
Lead Sponsor
Stanford Investigators
- Stephan Rogalla, M.D. Ph.D.
View full details

All Publications

Profiles With Related Publications

close
Allison Betof, MD, PhD, FASCO

Associate Professor of Medicine (Oncology)
Clinical Focus
Melanoma, Cellular Therapy, Medical Oncology

88 Total Publications
close
David Bingham

Clinical Associate Professor, Pathology
Clinical Focus
Anatomic and Clinical Pathology, Gastrointestinal Diseases

23 Total Publications
close
Nam Quoc Bui

Clinical Associate Professor, Medicine - Oncology
Clinical Focus
Medical Oncology, Soft Tissue Sarcoma, Bone Sarcoma, Gastrointestinal Stromal Tumors (GIST)

95 Total Publications
close
Jeffrey Bunker

Fellow in Medicine - Med/Infectious Diseases
Clinical Focus
Infectious Diseases, Internal Medicine, Fellow

12 Total Publications
close
Elwyn Cabebe

Clinical Focus
Medical Oncology, Clinical Trials, Gastrointestinal Malignancy, Cutaneous Oncology, Hospice and Palliative Care Medicine, Health Disparity, Minority and Vulnerable Populations, Breast Cancer, Filipino American
Research Interests
Gastrointerstinal Malignancies, Clinical Trials

9 Total Publications
close
Ruben J Colman, MD, PhD

Assistant Professor of Pediatrics (Gastroenterology)
Clinical Focus
Pediatric Gastroenterology, Inflammatory Bowel Diseases, Crohn's Disease, Ulcerative Colitis

44 Total Publications
close
Yuqin Dai

Director of Metabolomics

8 Total Publications
close
C. Garrison Fathman

Professor of Medicine (Immunology and Rheumatology), Emeritus
Research Interests
My lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.

329 Total Publications
close
Derek Holman

Casual Employee, Medicine - Med/Gastroenterology and Hepatology

13 Total Publications
close
Elizabeth Holman

Postdoctoral Scholar, Microbiology and Immunology
Research Interests
I currently explore the application of vibrational spectroscopic technologies for biomedical imaging and precision medicine for clinical use. My research interests are directly related to chemical imaging technology development, which include but are not limited to spectral and image processing and analysis, machine learning applications, autonomous adaptive data acquisition, and vibrational spectroscopic applications to the biomedical sciences.

11 Total Publications
close
Neeraja Kambham

Professor of Pathology
Clinical Focus
Renal Pathology, Medical Liver Pathology, Anatomic and Clinical Pathology
Research Interests
Dr. Kambham's research interests primarily involve medical diseases and transplantation pathology of the kidney and liver.

174 Total Publications
close
Judith Kraiczy, PhD

Basic Life Research Scientist, Obstetrics & Gynecology - Reproductive Endocrinology and Infertility (REI)

21 Total Publications